You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LGMD-2E/R4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are

Recruiting
  • Limb-girdle Muscular Dystrophy
    • Phoenix, Arizona
    • +14 more
    Aug 23, 2022

    Long-Term Development of Muscular Dystrophy Outcome Assessments

    Not yet recruiting
    • LGMD1A
    • +33 more
      • Richmond, Virginia
        Virginia Commonwealth University
      Aug 3, 2023

      Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)

      Enrolling by invitation
      • Limb Girdle Muscular Dystrophy
      • SRP-9003
      • Columbus, Ohio
        Nationwide Children's Hospital
      May 17, 2023

      Trial Readiness and Endpoint Assessment in LGMD R1

      Not yet recruiting
      • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
      • +3 more
        • Richmond, Virginia
          Virginia Commonwealth University
        Jan 10, 2023

        Limb-Girdle Muscular Dystrophy, Type 2E Trial in Columbus (SRP-9003)

        Active, not recruiting
        • Limb-Girdle Muscular Dystrophy, Type 2E
        • SRP-9003
        • Columbus, Ohio
          Nationwide Children's Hospital
        Sep 28, 2022

        Patients With Limb Girdle Muscular Distrophy Type 2E

        Completed
        • LGMD2E
        • Exon 3 truncating mutation
        • Any other mutation in SGBC gene
        • Milano, Italy
          IRCCS Ca' Granda Ospedale Maggiore Policlinico
        Mar 29, 2022

        Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)

        Enrolling by invitation
        • Limb Girdle Muscular Dystrophy
        • SRP-6004
        • Columbus, Ohio
          Nationwide Children's Hospital
        Jun 7, 2023

        Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

        Not yet recruiting
        • Limb Girdle Muscular Dystrophy
        • +8 more
        • LION-101 dose level 1
        • +2 more
        • (no location specified)
        Feb 17, 2022

        Aging Trial in Glendale

        Withdrawn
        • Aging
        • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
        • Control
        • Glendale, Arizona
          Glencroft Senior Living: Retirement Community in Arizona
        Jan 30, 2023

        Prevention, Type2Diabetes Trial in Winnipeg (Dialectical behavioral therapy, Lifestyle)

        Active, not recruiting
        • Prevention
        • Type2Diabetes
        • Dialectical behavioral therapy
        • Lifestyle
        • Winnipeg, Manitoba, Canada
          University of Manitoba
        Feb 2, 2023

        Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )

        Active, not recruiting
        • Vasovagal Syncope
        • midodrine hydrochloride
        • matching placebo
        • Minneapolis, Minnesota
        • +16 more
        Nov 1, 2022

        Cardiovascular Diseases, Type2diabetes Trial in Winnipeg (Peer mentorship and physical activity)

        Not yet recruiting
        • Cardiovascular Diseases
        • Type2diabetes
        • Peer mentorship and physical activity
        • Winnipeg, Manitoba, Canada
          University of Manitoba
        Feb 10, 2023

        Dementia Trial in Oakville, Toronto (Immersive VR Therapy in Head-Mounted Device (HMD))

        Not yet recruiting
        • Dementia
        • Immersive VR Therapy in Head-Mounted Device (HMD)
        • Oakville, Ontario, Canada
        • +3 more
        May 10, 2023

        Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

        Recruiting
        • Prostate Cancer Metastatic
        • Ablative Radiation Therapy
        • Standard of care
        • Victoria, British Columbia, Canada
        • +14 more
        Nov 14, 2022

        Local Recurrence Following Breast Conserving Surgery and

        Active, not recruiting
        • Breast Cancer
          • Calgary, Alberta, Canada
          • +26 more
          Sep 19, 2022

          Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

          Active, not recruiting
          • Oropharyngeal Cancer
          • Prince George, British Columbia, Canada
          • +13 more
          Dec 12, 2022

          Gestational Diabetes Trial in Canada (Resource bank, ePlatform, Health coach)

          Recruiting
          • Gestational Diabetes
          • Resource bank
          • +2 more
          • Calgary, Alberta, Canada
          • +5 more
          Sep 13, 2022

          Limb-Girdle Muscular Dystrophy Trial in Worldwide (Deflazacort)

          Terminated
          Has Results
          • Limb-Girdle Muscular Dystrophy
          • Atlanta, Georgia
          • +17 more
          May 31, 2022

          Adults With Severe Eosinophilic Asthma on Benralizumab.

          Active, not recruiting
          • Severe Eosinophilic Asthma
          • Survey Administration
          • Calgary, Alberta, Canada
          • +19 more
          Dec 1, 2022

          Disease Activity in Canadian Adult Moderate-to-Severe Atopic

          Recruiting
          • Atopic Dermatitis
            • Calgary, Alberta, Canada
            • +17 more
            Jan 17, 2023

            Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

            Not yet recruiting
            • Bipolar Disorder
            • Calgary, Alberta, Canada
            • +7 more
            May 18, 2023

            PLA2R-IgG4 Detection Kit

            Enrolling by invitation
            • Membranous Nephropathy - PLA2R Induced
            • Kidney Diseases-except Membranous Nephropathy
              • Hangzhou, China
                ZhejiangBiostar
              May 6, 2023

              Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))

              Recruiting
              • Solid Malignancy
              • Lymphoma
              • [18F] 4-L-Fluoroglutamine (2S,4R)
              • New York, New York
                Memorial Sloan Kettering Cancer Center
              Nov 28, 2022

              COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

              Recruiting
              • COVID-19
              • Calgary, Alberta, Canada
              • +56 more
              Jan 12, 2023

              Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

              Not yet recruiting
              • Diabetes Mellitus Type 2 With Proteinuria
              • +12 more
              • Empagliflozin 10 MG
              • +6 more
              • (no location specified)
              Oct 17, 2023